NCT00388037 2015-01-27Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerNational Cancer Institute (NCI)Phase 2 Completed31 enrolled 5 charts